Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...

A newly developed cardiac PET imaging technique offers a simpler way to detect significant coronary artery ...

Cite this: Peripheral Arterial Disease: Medical Care and Prevention of Complications - Medscape - Jun 01, 2002.

The Inter-Society Consensus for the Management of PAD (TASC II) published revised guidelines in 2007 that recommend goal LDL-C levels <100 mg/dl for all patients with PAD (level of evidence A) and ...

CAR T-cell therapy as option for diseases of the peripheral nervous system Our work shows that the targeted use of CAR T-cells is possible and of significant clinical benefit, even for severe ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published new, evidence-based clinical practice guidelines to support the treatment of chronic venous disease (CVD), a common and ...

Peripheral Artery Disease is a growing but often overlooked health threat in Southeast Missouri, where high rates of smoking ...

The goal of coronary artery bypass grafting (CABG) is to improve blood flow to your heart. The heart is a muscle about the size of your fist. Your heart pumps blood and oxygen to all of the organs and ...

CIDP is an autoimmune disease in which the immune system's B-cells attack the peripheral nervous system. In the current study, the CAR CD19 T-cell therapy was used to combat these rogue B-cells.